Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

UTHR

United Therapeutics (UTHR)

United Therapeutics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:UTHR
DateTimeSourceHeadlineSymbolCompany
12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
12/13/202310:03AMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:UTHRUnited Therapeutics Corporation
12/13/20239:15AMBusiness WireUnited Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and MergerNASDAQ:UTHRUnited Therapeutics Corporation
12/12/20234:37PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
12/12/202310:52AMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:UTHRUnited Therapeutics Corporation
12/12/20236:00AMBusiness WireUnited Therapeutics and Miromatrix Medical Announce Successful Tender OfferNASDAQ:UTHRUnited Therapeutics Corporation
12/07/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
12/07/20234:17PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
12/07/20236:00AMBusiness WireUnited Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024NASDAQ:UTHRUnited Therapeutics Corporation
12/04/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
12/04/20234:05PMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:UTHRUnited Therapeutics Corporation
12/01/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
11/29/20236:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:UTHRUnited Therapeutics Corporation
11/17/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
11/16/20236:01PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
11/13/20236:06AMEdgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:UTHRUnited Therapeutics Corporation
11/08/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
11/03/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
11/02/20235:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
11/01/20234:50PMEdgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:UTHRUnited Therapeutics Corporation
11/01/20234:50PMEdgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:UTHRUnited Therapeutics Corporation
11/01/20236:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:UTHRUnited Therapeutics Corporation
11/01/20236:03AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:UTHRUnited Therapeutics Corporation
11/01/20236:00AMBusiness WireUnited Therapeutics Corporation Reports Third Quarter 2023 Financial ResultsNASDAQ:UTHRUnited Therapeutics Corporation
10/31/20236:05AMBusiness WireUnited Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary FibrosisNASDAQ:UTHRUnited Therapeutics Corporation
10/31/20236:00AMBusiness WireUnited Therapeutics Corporation to Present at the UBS Biopharma Conference 2023NASDAQ:UTHRUnited Therapeutics Corporation
10/30/20237:09AMEdgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:UTHRUnited Therapeutics Corporation
10/30/20237:06AMEdgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:UTHRUnited Therapeutics Corporation
10/30/20236:05AMGlobeNewswire Inc.United Therapeutics to Acquire Miromatrix MedicalNASDAQ:UTHRUnited Therapeutics Corporation
10/30/20236:00AMBusiness WireUnited Therapeutics to Acquire Miromatrix MedicalNASDAQ:UTHRUnited Therapeutics Corporation
 Showing the most relevant articles for your search:NASDAQ:UTHR